10725819
Polio, hrr
items
https://raw.githubusercontent.com/jamesd4335/hrr2/master/hrr_pipes.csl
0
date
desc
203
https://healthresearchreport.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-826c965a9a2342c72e02b31088bc71ce%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22G35397TA%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Greer%22%2C%22parsedDate%22%3A%221955%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EVitamin%20C%20In%20Acute%20Poliomyelitis%3C%5C%2Fb%3E%23%23%211955%20%7C%20Greer%20E.%20%7C%20%3Ci%3EMedical%20Times%3C%5C%2Fi%3E.%20Published%20online%201955.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fwww.whale.to%5C%2Fa%5C%2Fgreer1955.html%27%3Ehttp%3A%5C%2F%5C%2Fwww.whale.to%5C%2Fa%5C%2Fgreer1955.html%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vitamin%20C%20In%20Acute%20Poliomyelitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Greer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%221955%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.whale.to%5C%2Fa%5C%2Fgreer1955.html%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T23%3A18%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22NC8WP7BB%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22GALLOWAY%20and%20SEIFERT%22%2C%22parsedDate%22%3A%221949-09-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EBULBAR%20POLIOMYELITIS%3A%20Favorable%20Results%20in%20Its%20Treatment%20as%20a%20Problem%20in%20Respiratory%20Obstruction%3C%5C%2Fb%3E%23%23%211949%20%7C%20GALLOWAY%20TC%2C%20SEIFERT%20MH.%20%7C%20%3Ci%3EJournal%20of%20the%20American%20Medical%20Association%3C%5C%2Fi%3E.%201949%3B141%281%29%3A1-8.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1949.02910010003001%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1949.02910010003001%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22BULBAR%20POLIOMYELITIS%3A%20Favorable%20Results%20in%20Its%20Treatment%20as%20a%20Problem%20in%20Respiratory%20Obstruction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22THOMAS%20C.%22%2C%22lastName%22%3A%22GALLOWAY%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MARTIN%20H.%22%2C%22lastName%22%3A%22SEIFERT%22%7D%5D%2C%22abstractNote%22%3A%22In%20bulbar%20poliomyelitis%20it%20has%20usually%20been%20assumed%20that%20the%20grave%20effects%20were%20due%20to%20the%20direct%20action%20of%20the%20virus%20itself%20on%20the%20central%20nervous%20system.%20In%201943%2C%20one%20of%20us%20%28T.%20C.G.%291%20presented%20the%20idea%20that%20secretional%20obstruction%20and%20anoxia%20were%20much%20more%20important.%20During%20the%20ensuing%20time%20that%20conviction%20has%20grown.%20In%20the%20past%20two%20years%20we%20have%20been%20able%20to%20key%20our%20treatment%20to%20that%20concept.With%20such%20treatment%20in%20the%20past%20two%20and%20one-half%20years%20at%20the%20Evanston%20Hospital%2C%20we%20have%20had%20no%20deaths%20in%2015%20cases%20of%20bulbar%20poliomyelitis.%20The%20mortality%20rate%20for%20the%20bulbar%20form%20of%20the%20disease%20was%2038.8%20per%20cent%20in%20Illinois%20outside%20of%20Chicago%20during%201947%20and%201948.2%20The%20mortality%20rate%20among%20residents%20of%20Chicago%20was%2027%20per%20cent%20in%201948%2C%20for%20which%20figures%20are%20available3%20%28table%29.%20Our%20favorable%20results%20in%20the%20same%20region%20during%20the%20same%22%2C%22date%22%3A%221949-09-03%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1001%5C%2Fjama.1949.02910010003001%22%2C%22ISSN%22%3A%220002-9955%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.1949.02910010003001%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T23%3A18%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22VRJY9RCS%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jungeblut%22%2C%22parsedDate%22%3A%221939-08-31%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EA%20FURTHER%20CONTRIBUTION%20TO%20VITAMIN%20C%20THERAPY%20IN%20EXPERIMENTAL%20POLIOMYELITIS%3C%5C%2Fb%3E%23%23%211939%20%7C%20Jungeblut%20CW.%20%7C%20%3Ci%3EJ%20Exp%20Med%3C%5C%2Fi%3E.%201939%3B70%283%29%3A315-332.%20%23%23%21%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133810%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133810%5C%2F%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20FURTHER%20CONTRIBUTION%20TO%20VITAMIN%20C%20THERAPY%20IN%20EXPERIMENTAL%20POLIOMYELITIS%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claus%20W.%22%2C%22lastName%22%3A%22Jungeblut%22%7D%5D%2C%22abstractNote%22%3A%221.%20Multiple%20paralytic%20doses%20of%20poliomyelitis%20virus%20%28RMV%20strain%29%2C%20when%20brought%20together%20with%20small%20amounts%20of%20synthetic%20ascorbic%20acid%20in%20vitro%2C%20are%20rendered%20non-infectious%20as%20determined%20by%20intracerebral%20injection%20of%20such%20mixtures%20into%20rhesus%20monkeys.%202.%20Vitamin%20C%20administration%20to%20monkeys%20infected%20intranasally%20with%20the%20RMV%20strain%20produces%20results%20which%20differ%20in%20accordance%20with%20the%20technique%20employed%20for%20nasal%20instillation.%20With%20an%20infection%20of%20maximum%20severity%2C%20induced%20by%20flooding%20the%20nasal%20portal%20of%20entry%20with%20large%20amounts%20of%20virus%2C%20vitamin%20C%20administration%20fails%20to%20exert%20any%20demonstrable%20influence%20on%20the%20course%20of%20the%20disease.%20With%20a%20less%20forceful%20method%20of%20droplet%20instillation%2C%20the%20picture%20of%20the%20disease%20in%20control%20animals%20becomes%20so%20variable%20that%20the%20results%20cannot%20be%20easily%20interpreted%3B%20but%20the%20available%20data%20suggest%20that%20vitamin%20C%20treatment%20may%20be%20a%20factor%20in%20converting%20abortive%20attacks%20into%20an%20altogether%20non-paralytic%20infection.%203.%20The%20administration%20of%20synthetic%20vitamin%20C%20to%20monkeys%20infected%20intracerebrally%20with%20small%20doses%20of%20the%20RMV%20strain%20gives%20results%20comparable%20to%20those%20previously%20obtained%20with%20this%20substance%20in%20monkeys%20infected%20intracerebrally%20with%20the%20Aycock%20strain%20of%20poliomyelitis%20virus.%204.%20The%20implications%20of%20the%20findings%20are%20discussed.%22%2C%22date%22%3A%221939-8-31%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220022-1007%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133810%5C%2F%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T20%3A13%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22PK3NU478%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jungeblut%22%2C%22parsedDate%22%3A%221937-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EVITAMIN%20C%20THERAPY%20AND%20PROPHYLAXIS%20IN%20EXPERIMENTAL%20POLIOMYELITIS%3C%5C%2Fb%3E%23%23%211937%20%7C%20Jungeblut%20CW.%20%7C%20%3Ci%3EJ%20Exp%20Med%3C%5C%2Fi%3E.%201937%3B65%281%29%3A127-146.%20%23%23%21%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133474%5C%2F%27%3Ehttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133474%5C%2F%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22VITAMIN%20C%20THERAPY%20AND%20PROPHYLAXIS%20IN%20EXPERIMENTAL%20POLIOMYELITIS%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claus%20W.%22%2C%22lastName%22%3A%22Jungeblut%22%7D%5D%2C%22abstractNote%22%3A%221.%20A%20group%20of%2034%20monkeys%20were%20infected%20intracerebrally%20with%200.1%20cc.%20of%20a%2010%20per%20cent%20virus%20suspension.%20Following%20infection%2C%209%20animals%20were%20treated%20with%20daily%20injections%20of%20700%20to%20100%20mg.%2C%2016%20with%2050%20to%2010%20mg.%20and%209%20with%205%20mg.%20of%20vitamin%20C%20for%20a%20period%20of%202%20weeks.%20In%20the%20whole%20group%20there%20were%206%20animals%20that%20survived%20without%20showing%20any%20evidence%20of%20paralysis.%202%20of%20these%20had%20received%2050%20to%2010%20mg.%20while%204%20had%20received%205%20mg.%20All%20of%2019%20untreated%20control%20monkeys%2C%20infected%20simultaneously%20with%20the%20same%20amount%20of%20virus%2C%20developed%20paralysis.%202.%20Another%20group%20of%206%20monkeys%20were%20infected%20intracerebrally%20with%200.05%20cc.%20of%20virus.%20Following%20infection%2C%20one%20animal%20was%20treated%20in%20the%20same%20manner%20with%2025%20mg.%20and%205%20with%205%20mg.%20of%20vitamin%20C.%20In%20the%20whole%20group%20there%20was%20one%20animal%20that%20survived%20without%20showing%20any%20evidence%20of%20paralysis.%20This%20animal%20had%20received%205%20mg.%20All%20of%207%20untreated%20control%20monkeys%2C%20infected%20simultaneously%20with%20the%20same%20amount%20of%20virus%2C%20developed%20paralysis.%203.%20A%20third%20group%20of%2022%20monkeys%20were%20infected%20intracerebrally%20with%200.01%20cc.%20of%20virus.%20Following%20infection%2C%20one%20animal%20was%20treated%20in%20the%20same%20manner%20with%20100%20mg.%2C%202%20with%2050%20to%2010%20mg.%2C%20and%2019%20with%205%20mg.%20of%20vitamin%20C.%20In%20the%20whole%20group%20there%20were%2012%20animals%20that%20survived%20without%20showing%20any%20evidence%20of%20paralysis.%20One%20of%20these%20had%20received%2010%20mg.%2C%20while%2011%20had%20received%205%20mg.%20Of%2012%20untreated%20control%20monkeys%2C%20infected%20simultaneously%20with%20the%20same%20amount%20of%20virus%2C%202%20failed%20to%20show%20any%20paralytic%20symptoms%20and%2010%20developed%20paralysis.%204.%20A%20summary%20of%20the%20results%20obtained%20in%20all%20three%20groups%20shows%3A%20%28a%29%20that%20among%20a%20total%20of%2062%20treated%20monkeys%2C%2019%20survived%20without%20paralysis%20and%2043%20succumbed%20to%20the%20disease%2C%20while%20of%20a%20total%20of%2038%20untreated%20controls%2C%20only%202%20failed%20to%20develop%20paralysis%20and%2036%20succumbed%20to%20the%20disease%3B%20%28b%29%20that%20treatment%20with%20large%20doses%20of%20vitamin%20C%20was%20without%20any%20beneficial%20effect%20%28all%2010%20monkeys%20which%20had%20received%20700%20to%20100%20mg.%20developing%20paralysis%2C%20that%20the%20administration%20of%20intermediate%20doses%20was%20followed%20by%20occasional%20survival%20without%20paralysis%20of%20the%20treated%20animal%20%283%20monkeys%20surviving%20of%20a%20total%20of%2019%20which%20had%20received%2050%20to%2010%20mg.%29%2C%20and%20that%20nearly%20one-half%20of%20the%20animals%20which%20had%20received%20small%20doses%20escaped%20the%20disease%20%2816%20monkeys%20surviving%20of%20a%20total%20of%2033%20which%20had%20received%205%20mg.%29.%205.%20Attempts%20to%20protect%20monkeys%20against%20subsequent%20intracerebral%20infection%20by%20the%20prophylactic%20administration%20of%20vitamin%20C%2C%20either%20per%20os%20or%20parenterally%2C%20have%20produced%20negative%20results.%206.%20The%20pathogenesis%20of%20infantile%20paralysis%20is%20discussed%20in%20the%20light%20of%20the%20experimental%20findings%20and%20the%20possibility%20is%20suggested%20that%20vitamin%20C%20represents%20one%20of%20the%20deficiency%20factors%20in%20the%20susceptibility%20problem%20of%20the%20human%20disease.%22%2C%22date%22%3A%221937-1-1%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220022-1007%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC2133474%5C%2F%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T23%3A18%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22AAWUIQJU%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jungeblut%22%2C%22parsedDate%22%3A%221935-09-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EINACTIVATION%20OF%20POLIOMYELITIS%20VIRUS%20IN%20VITRO%20BY%20CRYSTALLINE%20VITAMIN%20C%20%28ASCORBIC%20ACID%29%3C%5C%2Fb%3E%23%23%211935%20%7C%20Jungeblut%20CW.%20%7C%20%3Ci%3EJ%20Exp%20Med%3C%5C%2Fi%3E.%201935%3B62%284%29%3A517-521.%20%23%23%21%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1084%5C%2Fjem.62.4.517%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1084%5C%2Fjem.62.4.517%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22INACTIVATION%20OF%20POLIOMYELITIS%20VIRUS%20IN%20VITRO%20BY%20CRYSTALLINE%20VITAMIN%20C%20%28ASCORBIC%20ACID%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Jungeblut%22%7D%5D%2C%22abstractNote%22%3A%22The%20experimental%20evidence%20presented%20in%20this%20paper%20shows%20that%20multiple%20paralytic%20doses%20of%20poliomyelitis%20virus%2C%20when%20mixed%20with%20very%20small%20amounts%20of%20crystalline%20vitamin%20C%20%28ascorbic%20acid%29%2C%20are%20rendered%20non-infectious%20as%20determined%20by%20intracerebral%20injection%20of%20such%20mixtures%20into%20rhesus%20monkeys.%22%2C%22date%22%3A%221935-09-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1084%5C%2Fjem.62.4.517%22%2C%22ISSN%22%3A%220022-1007%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T23%3A18%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22RARJZ8DM%22%2C%22library%22%3A%7B%22id%22%3A10725819%7D%2C%22meta%22%3A%7B%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cb%3EThe%20Treatment%20of%20Poliomyelitis%20and%20Other%20Virus%20Diseases%20with%20Vitamin%20C%3C%5C%2Fb%3E%23%23%21%3Cb%3EThe%20Treatment%20of%20Poliomyelitis%20and%20Other%20Virus%20Diseases%20with%20Vitamin%20C%3C%5C%2Fb%3E.%20%7C%20%23%23%21%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fseanet.com%5C%2F~alexs%5C%2Fascorbate%5C%2F194x%5C%2Fklenner-fr-southern_med_surg-1949-v111-n7-p209.htm%27%3Ehttps%3A%5C%2F%5C%2Fseanet.com%5C%2F~alexs%5C%2Fascorbate%5C%2F194x%5C%2Fklenner-fr-southern_med_surg-1949-v111-n7-p209.htm%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Treatment%20of%20Poliomyelitis%20and%20Other%20Virus%20Diseases%20with%20Vitamin%20C%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fseanet.com%5C%2F~alexs%5C%2Fascorbate%5C%2F194x%5C%2Fklenner-fr-southern_med_surg-1949-v111-n7-p209.htm%22%2C%22collections%22%3A%5B%22VFY3LYPC%22%5D%2C%22dateModified%22%3A%222023-01-12T23%3A18%3A37Z%22%7D%7D%5D%7D
Vitamin C In Acute Poliomyelitis##!1955 | Greer E. | Medical Times. Published online 1955. ##!http://www.whale.to/a/greer1955.html
BULBAR POLIOMYELITIS: Favorable Results in Its Treatment as a Problem in Respiratory Obstruction##!1949 | GALLOWAY TC, SEIFERT MH. | Journal of the American Medical Association. 1949;141(1):1-8. ##!http://doi.org/10.1001/jama.1949.02910010003001
A FURTHER CONTRIBUTION TO VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS##!1939 | Jungeblut CW. | J Exp Med. 1939;70(3):315-332. ##!https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133810/
VITAMIN C THERAPY AND PROPHYLAXIS IN EXPERIMENTAL POLIOMYELITIS##!1937 | Jungeblut CW. | J Exp Med. 1937;65(1):127-146. ##!https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133474/
INACTIVATION OF POLIOMYELITIS VIRUS IN VITRO BY CRYSTALLINE VITAMIN C (ASCORBIC ACID)##!1935 | Jungeblut CW. | J Exp Med. 1935;62(4):517-521. ##!http://doi.org/10.1084/jem.62.4.517
The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C##!The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C. | ##!https://seanet.com/~alexs/ascorbate/194x/klenner-fr-southern_med_surg-1949-v111-n7-p209.htm